文献速递肺栓塞与肺血管病

骨髓增殖性肿瘤相关肺动脉高压的临床表型与结局:一项基于人群的研究

Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

结果显示患者血流动力学损害严重,半数诊断为慢性血栓栓塞性肺动脉高压(CTEPH),另半数为第5组肺动脉高压;第5组生存率低于CTEPH。

要点

  • MPN相关肺动脉高压患者血流动力学损害严重,中位平均肺动脉压42 mmHg、肺血管阻力6.7 Wood单位。
  • 约半数患者诊断为CTEPH,另半数为第5组肺动脉高压;MF多与第5组相关,PV和ET多与CTEPH相关。
  • 第5组肺动脉高压1、3、5年生存率分别为67%、50%、34%,低于CTEPH的81%、66%、42%。

核心结论

  • 肺动脉高压是MPN可能发生的危及生命的并发症,机制多样,CTEPH与第5组肺动脉高压诊断比例相当。
  • 医生应意识到肺动脉高压显著影响MPN患者疾病负担,尤其是病理生理机制不明的第5组肺动脉高压。

主要发现

  • 71%患者为NYHA功能III/IV级,中位6分钟步行距离310 m。
  • 半数患者诊断为CTEPH,另半数为第5组肺动脉高压;MF多与第5组相关,PV和ET多与CTEPH相关。
  • CTEPH患者中半数诊断近端病变;18例高危并发症患者接受血栓内膜剥脱术,其中5例早期死亡。
  • 第5组肺动脉高压1、3、5年总生存率分别为67%、50%、34%,CTEPH分别为81%、66%、42%。

临床怎么用

  • 对MPN患者应警惕肺动脉高压可能,尽早行超声心动图等评估。
  • MPN相关肺动脉高压需鉴别CTEPH与第5组肺动脉高压,前者可考虑血栓内膜剥脱术但需评估手术风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Precapillary pulmonary hypertension (PH) is a rare and largely unrecognized complication of myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (MF). Objectives: To describe characteristics and outcomes of MPN-associated PH. Methods: We report clinical, functional, and hemodynamic characteristics, classification, and outcomes of patients with PV, ET, or primary MF in the French PH registry. Measurements and Main Results: Ninety patients with MPN (42 PV, 35 ET, 13 primary MF) presented with precapillary PH with severe hemodynamic impairment, with a median mean pulmonary arterial pressure and pulmonary vascular resistance of 42 mm Hg and 6.7 Wood units, respectively, and impaired clinical conditions, with 71% in New York Heart Association functional classes III/IV and having a median 6-minute-walk distance of 310 m. Half of the patients were diagnosed with chronic thromboembolic PH (CTEPH); the other half were considered to have group 5 PH. MF was preferentially associated with group 5 PH, whereas PV and ET were generally related to CTEPH. Proximal lesions were diagnosed in half of the patients with CTEPH. Thromboendarterectomy was performed in 18 selected patients with high risk of complications (5 early deaths). Overall survival at 1, 3, and 5 years was 67%, 50%, and 34% in group 5 PH and 81%, 66%, and 42% in CTEPH, respectively. Conclusions: PH is a life-threatening condition potentially occurring in MPN. There are multiple mechanisms, with equal diagnoses of CTEPH and group 5 PH. Physicians should be aware that PH strongly affects the burden of patients with MPN, especially in group 5 PH, with unknown pathophysiological mechanisms.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Montani D, Thoré P, Mignard X, et al. Clinical Phenotype and Outcomes of Pulmonary Hypertension Associated with Myeloproliferative Neoplasms: A Population-based Study. Am J Respir Crit Care Med. 2023. PMID: 37311222. doi:10.1164/rccm.202210-1941OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。